Dr. Amit Gupta, MD

Claim this profile

John Radcliffe Hospital

Studies Bladder Cancer
Studies Lung Injury
3 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
Cedars-Sinai Medical Center

Clinical Trials Amit Gupta, MD is currently running

Image of trial facility.

PEEP Levels

for Premature Birth

Premature babies often need help immediately after birth to open their lungs to air, start breathing and keep their hearts beating. Opening their lungs can be difficult, and once open the under-developed lungs of premature babies will often collapse again between each breath. To prevent this nearly all premature babies receive some form of mechanical respiratory support to aid breathing. Common to all types of respiratory support is the delivery of a treatment called positive end-expiratory pressure, or PEEP. PEEP gives air, or a mixture of air and oxygen, to the lung between each breath to keep the lungs open and stop them collapsing. Currently, clinicians do not have enough evidence on the right amount, or level, of PEEP to give at birth. As a result, doctors around the world give different amounts (or levels) of PEEP to premature babies at birth. In this study, the Investigators will look at 2 different approaches to PEEP to help premature babies during their first breaths at birth. At the moment, the Investigators do not know if one is better than the other. One is to give the same PEEP level to the lungs. The others is to give a high PEEP level at birth when the lungs are hardest to open and then decrease the PEEP later once the lungs are opened and the baby is breathing. Very premature babies have a risk of long-term lung disease (chronic lung disease). The more breathing support a premature baby needs, the more likely the risk of developing chronic lung disease. The Investigators want to find out whether one method of opening the baby's lungs at birth results in them needing less breathing support. This research has been initiated by a group of doctors from Australia, the Netherlands and the USA, all who look after premature babies.
Recruiting1 award N/A3 criteria

More about Amit Gupta, MD

Clinical Trial Related7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Amit Gupta, MD has experience with
  • Positive End-Expiratory Pressure (PEEP)
  • A Novel Multiplex ELISA Assay
  • Intravesical BCG

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Gupta, MD specialize in?
Amit Gupta, MD focuses on Bladder Cancer and Lung Injury. In particular, much of their work with Bladder Cancer has involved treating patients, or patients who are undergoing treatment.
Is Amit Gupta, MD currently recruiting for clinical trials?
Yes, Amit Gupta, MD is currently recruiting for 1 clinical trial in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Amit Gupta, MD has studied deeply?
Yes, Amit Gupta, MD has studied treatments such as Positive End-Expiratory Pressure (PEEP), A Novel Multiplex ELISA Assay, Intravesical BCG.
What is the best way to schedule an appointment with Amit Gupta, MD?
Apply for one of the trials that Amit Gupta, MD is conducting.
What is the office address of Amit Gupta, MD?
The office of Amit Gupta, MD is located at: Cedars-Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars-Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.